Literature DB >> 33546427

Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain Metastases.

Petra A Mercea1, Mario Mischkulnig1, Barbara Kiesel1, Lisa I Wadiura1, Thomas Roetzer2, Romana Prihoda1, Patricia Heicappell3, Judith Kreminger3, Julia Furtner4, Adelheid Woehrer2, Matthias Preusser3, Karl Roessler1, Anna S Berghoff3, Georg Widhalm1.   

Abstract

Complete resection is an indispensable treatment option in the management of brain metastases (BM). 5-aminolevulinic acid (5-ALA) fluorescence is used for improved intraoperative visualization of tumor tissue in gliomas and was recently observed in BM. We investigated the potential of 5-ALA fluorescence to visualize the infiltrative growth of BM in the peritumoral brain tissue and its histopathological correlate. Patients with BM resection after 5-ALA administration and collection of tissue samples from peritumoral brain tissue were included. Each tissue sample was histopathologically investigated for tumor cell infiltration and angiogenesis. Altogether, 88 samples were collected from the peritumoral brain tissue in 58 BM of 55 patients. Visible 5-ALA fluorescence was found in 61 (69%) of the samples, tumor infiltration in 19 (22%) and angiogenesis in 13 (15%) of samples. Angiogenesis showed a significant correlation with presence of fluorescence (p = 0.008). Moreover, angiogenesis was related to visible 5-ALA fluorescence and showed an association with patient prognosis since it was significantly correlated to shorter time to local progression/recurrence (p = 0.001) and lower one-year survival (p = 0.031). Consequently, angiogenesis in the peritumoral brain tissue of BM might be a novel prognostic marker for individualized perioperative treatment concepts in the future.

Entities:  

Keywords:  5-ALA; angiogenesis; brain metastases; local recurrence/progression; peritumoral brain tissue

Year:  2021        PMID: 33546427      PMCID: PMC7913757          DOI: 10.3390/cancers13040603

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  26 in total

1.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

2.  Detailed analysis of 5-aminolevulinic acid induced fluorescence in different brain metastases at two specialized neurosurgical centers: experience in 157 cases.

Authors:  Franz Marhold; Petra A Mercea; Florian Scheichel; Anna S Berghoff; Patricia Heicappell; Barbara Kiesel; Mario Mischkulnig; Martin Borkovec; Stefan Wolfsberger; Adelheid Woehrer; Matthias Preusser; Engelbert Knosp; Karl Ungersboeck; Georg Widhalm
Journal:  J Neurosurg       Date:  2019-09-27       Impact factor: 5.115

3.  Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.

Authors:  David W Roberts; Pablo A Valdés; Brent T Harris; Kathryn M Fontaine; Alexander Hartov; Xiaoyao Fan; Songbai Ji; S Scott Lollis; Brian W Pogue; Frederic Leblond; Tor D Tosteson; Brian C Wilson; Keith D Paulsen
Journal:  J Neurosurg       Date:  2010-04-09       Impact factor: 5.115

Review 4.  Brain metastases: pathobiology and emerging targeted therapies.

Authors:  Matthias Preusser; David Capper; Aysegül Ilhan-Mutlu; Anna Sophie Berghoff; Peter Birner; Rupert Bartsch; Christine Marosi; Christoph Zielinski; Minesh P Mehta; Frank Winkler; Wolfgang Wick; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2012-01-03       Impact factor: 17.088

Review 5.  Brain metastases: epidemiology and pathophysiology.

Authors:  Igor T Gavrilovic; Jerome B Posner
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

6.  Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases.

Authors:  Thomas Spanberger; Anna S Berghoff; Carina Dinhof; Aysegül Ilhan-Mutlu; Manuel Magerle; Markus Hutterer; Josef Pichler; Adelheid Wöhrer; Monika Hackl; Georg Widhalm; Johannes A Hainfellner; Karin Dieckmann; Christine Marosi; Peter Birner; Daniela Prayer; Matthias Preusser
Journal:  Clin Exp Metastasis       Date:  2012-10-17       Impact factor: 5.150

Review 7.  What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?

Authors:  Costas G Hadjipanayis; Georg Widhalm; Walter Stummer
Journal:  Neurosurgery       Date:  2015-11       Impact factor: 4.654

8.  The metastatic infiltration at the metastasis/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective study.

Authors:  Laila Siam; Annalen Bleckmann; Han-Ning Chaung; Alexander Mohr; Florian Klemm; Alonso Barrantes-Freer; Raquel Blazquez; Hendrik A Wolff; Florian Lüke; Veit Rohde; Christine Stadelmann; Tobias Pukrop
Journal:  Oncotarget       Date:  2015-10-06

9.  Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model.

Authors:  A Obwegeser; R Jakober; H Kostron
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

10.  5-ALA fluorescence of cerebral metastases and its impact for the local-in-brain progression.

Authors:  Marcel A Kamp; Igor Fischer; Julia Bühner; Bernd Turowski; Jan Frederick Cornelius; Hans-Jakob Steiger; Marion Rapp; Philipp J Slotty; Michael Sabel
Journal:  Oncotarget       Date:  2016-10-11
View more
  4 in total

1.  MRI-Based Risk Assessment for Incomplete Resection of Brain Metastases.

Authors:  Tizian Rosenstock; Paul Pöser; David Wasilewski; Hans-Christian Bauknecht; Ulrike Grittner; Thomas Picht; Martin Misch; Julia Sophie Onken; Peter Vajkoczy
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

2.  Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type Glioblastoma.

Authors:  Johannes Wach; Ági Güresir; Motaz Hamed; Hartmut Vatter; Ulrich Herrlinger; Erdem Güresir
Journal:  Cancers (Basel)       Date:  2022-04-25       Impact factor: 6.575

3.  Evolutionary Trend Analysis of Research on 5-ALA Delivery and Theranostic Applications Based on a Scientometrics Study.

Authors:  You Zhou; Mulan Mo; Dexu Luo; Yi Yang; Jialin Hu; Chenqing Ye; Longxiang Lin; Chuanshan Xu; Wenjie Chen
Journal:  Pharmaceutics       Date:  2022-07-15       Impact factor: 6.525

4.  GT198 Is a Target of Oncology Drugs and Anticancer Herbs.

Authors:  Junfeng Pang; Jie Gao; Liyong Zhang; Nahid F Mivechi; Lan Ko
Journal:  Front Oral Health       Date:  2021-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.